๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC

โœ Scribed by Xiao-Dong Jiang, Yun Qiao, Peng Dai, Jin Wu, Da-An Song, Shi-Qiu Li, Yue-Wei Fan

Book ID
113094861
Publisher
Springer Milan
Year
2012
Tongue
Spanish
Weight
724 KB
Volume
14
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase I clinical and pharmacologic stu
A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma
โœ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB ๐Ÿ‘ 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist